{"composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_target_lines":[],"graph_title":"global_indicators.3-3-4-title","graph_titles":[],"graph_type":"line","indicator_name":"global_indicators.3-3-4-title","indicator_number":"3.3.4","national_geographical_coverage":"","page_content":"GRAFICO.3-3-4-contenido","permalink":"","precision":[],"progress_status":"alcanzado","reporting_status":"complete","sort":"","sources":[{"organisation":"FUENTE.GE_Sanidad","periodicity":"FUENTE.FREQ_A","url":"FUENTE.GE_Sanidad_edo_url","url_text":"FUENTE.GE_Sanidad_edo","logo":"FUENTE.GE_logo"}],"standalone":false,"tags":null,"indicador_disponible":"global_indicators.3-3-4-title","objetivo_global":"objetivo_largo.3-titulo","meta_global":"meta_largo.3-3-titulo","definicion":"Zaintza Epidemiologikoko Sare Nazionalari (RENAVE) jakinarazitako B hepatitisaren kasu autoktonoak, 100.000 biztanleko","formula":"\n$$TCA_{B\\, hepatitisa}^{t} = \\frac{CA_{B\\, hepatitisa}^{t}}{P^{t}} \\cdot 100.000$$\n\nnon:\n\n$CA_{B\\, hepatitisa}^{t} =$ Zaintza Epidemiologikoko Sare Nazionalari (RENAVE) jakinarazitako B hepatitisaren kasu autoktonoak $t$ urtean \n\n$P^{t} =$ biztanleria $t$ urteko uztailaren 1ean \n","desagregacion":"Sexua","periodicidad":"FUENTE.FREQ_A","observaciones":"Kasu autoktonoak dira gaixotasuna lurralde nazionalean harrapatu dutenak.","texto_oceca":"FUENTE.oceca","justificacion_global":"\nAsmoa da B hepatitisaren ziozko infekzio kronikoen murrizketa deskribatzea. GIBaren ondoriozko infekzioaren \ngaixotasun-karga handiena 5 urteak bete baino lehen hartutako infekzioetatik dator. Ondorioz, GIBaren infekzioaren \nprebentzioa 5 urtetik beherako haurrengan lantzen da bereziki. Nazio Batuek 5 urtekoen GIBaren ondoriozko infekzio \nkronikoen intzidentziaren metaketa aukeratu zuten \u201chepatitisari aurre egiteko\u201d helburuaren adierazle gisa. Adierazle \nhori zuzenean neurtzen da GIBaren ziozko infekzio kronikoa garatu duten 5 urteko haurren proportzioaren bidez \n(hau da, hepatitisaren azalera-antigenoa izeneko infekzio-proba markatzaile batean positibo eman dutenen proportzioa \n[HBsAg]).\n\nAdierazle hori zuzenean neurtzen da GIBaren ziozko infekzio kronikoa garatu duten 5 urteko haurren proportzioaren \nbidez (hau da, hepatitisaren azalera-antigenoa izeneko infekzio proba markatzaile batean positibo eman dutenen \nproportzioa [HBsAg]). \n\n\nIturria: Nazio Batuen Estatistika Sekzioa \n","dato_global":"<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.3.4&seriesCode=SH_HAP_HBSAG&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=%3C5Y\">B hepatitisaren gainazaleko antigenoaren prebalentzia (HBsAg) (%) SH_HAP_HBSAG</a> UNSTATS","comparabilidad":"Eskuragarri dagoen adierazleak ez ditu Nazio Batuen metadatuak betetzen, baina antzeko informazioa ematen du","indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-03-04.pdf\">Metadatuak 3-3-4.pdf</a> (ingelesez bakarrik)","national_data_updated_date":"2025-05-08","national_metadata_updated_date":"2025-06-18","es":{"indicador_disponible":"global_indicators.3-3-4-title","objetivo_global":"objetivo_largo.3-titulo","meta_global":"meta_largo.3-3-titulo","definicion":"Casos aut\u00f3ctonos de hepatitis B notificados a la Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE) por cada 100.000 habitantes","formula":"\n$$TCA_{hepatitis\\, B}^{t} = \\frac{CA_{hepatitis\\, B}^{t}}{P^{t}} \\cdot 100.000$$\n\ndonde:\n\n$CA_{hepatitis\\, B}^{t} =$ casos aut\u00f3ctonos de hepatitis B notificados a la Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE) en el a\u00f1o $t$\n\n$P^{t} =$ poblaci\u00f3n a 1 de julio del a\u00f1o $t$\n","desagregacion":"Sexo","periodicidad":"FUENTE.FREQ_A","observaciones":"Los casos aut\u00f3ctonos son aquellos en los que la enfermedad se ha contra\u00eddo en el territorio nacional.","texto_oceca":"FUENTE.oceca","justificacion_global":"\nEl prop\u00f3sito es describir la reducci\u00f3n de las infecciones cr\u00f3nicas por hepatitis B. La mayor parte de la carga \nde enfermedad por infecci\u00f3n por VHB proviene de infecciones adquiridas antes de los 5 a\u00f1os de edad. Por lo tanto, \nla prevenci\u00f3n de la infecci\u00f3n por VHB se centra en ni\u00f1os menores de 5 a\u00f1os. Las Naciones Unidas seleccionaron \nel acumulado de la incidencia de infecci\u00f3n cr\u00f3nica por VHB a los 5 a\u00f1os de edad como indicador del objetivo de \n\u201ccombatir la hepatitis\u201d. Este indicador se mide indirectamente a trav\u00e9s de la proporci\u00f3n de ni\u00f1os 5 a\u00f1os de edad \nque han desarrollado una infecci\u00f3n cr\u00f3nica por VHB (es decir, la proporci\u00f3n que da positivo en una \nprueba marcador de infecci\u00f3n llamado ant\u00edgeno de superficie de la hepatitis B [HBsAg]).\n\nEste indicador se mide indirectamente a trav\u00e9s de la proporci\u00f3n de ni\u00f1os de 5 a\u00f1os que han desarrollado una \ninfecci\u00f3n cr\u00f3nica por VHB (es decir, la proporci\u00f3n que da positivo para un marcador de infecci\u00f3n llamado \nant\u00edgeno de superficie de la hepatitis B [HBsAg]). \n\nFuente: Divisi\u00f3n de Estad\u00edsticas de las Naciones Unidas \n","dato_global":"<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.3.4&seriesCode=SH_HAP_HBSAG&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=%3C5Y\">Prevalencia del ant\u00edgeno de superficie de la hepatitis B (HBsAg) (%) SH_HAP_HBSAG</a> UNSTATS","comparabilidad":"El indicador disponible no cumple con los metadatos de Naciones Unidas, pero aporta informaci\u00f3n similar","indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-03-04.pdf\">Metadatos 3-3-4.pdf</a> (solo en ingl\u00e9s)"},"en":{"indicador_disponible":"global_indicators.3-3-4-title","objetivo_global":"objetivo_largo.3-titulo","meta_global":"meta_largo.3-3-titulo","definicion":"Autochthonous cases of hepatitis B notified to the National Epidemiological Surveillance Network (RENAVE) per 100,000 inhabitants","formula":"\n$$TCA_{hepatitis B}^{t} = \\frac{CA_{hepatitis B}^{t}}{P^{t}} \\cdot 100.000$$\n\nwhere:\n\n$CA_{hepatitis B}^{t} =$ autochthonous cases of hepatitis B notified to the National Epidemiological Surveillance Network (RENAVE) in year $t$\n\n$P^{t} =$ population on July 1 of year $t$\n","desagregacion":"Sex","periodicidad":"FUENTE.FREQ_A","observaciones":"Autochthonous cases are those in which the disease has been contracted in the national territory.","texto_oceca":"FUENTE.oceca","justificacion_global":"\nThe purpose is to describe the reduction in chronic hepatitis b infections. Most of the burden of disease \nfrom HBV infection comes from infections acquired before the age of 5 years. Therefore, prevention of \nHBV infection focuses on children under 5 years of age. The United Nations selected the cumulative \nincidence of chronic HBV infection at 5 years of age as an indicator of the Sustainable Development Goal \ntarget for \u201ccombating hepatitis\u201d. This indicator is measured indirectly through the proportion of children \n5 years of age who have developed chronic HBV infection (i.e. the proportion that tests positive for a \nmarker of infection called hepatitis B surface antigen [HBsAg]).\n\nThis indicator is measured indirectly through the proportion of children 5 years of age who have \ndeveloped chronic HBV infection (i.e. the proportion that tests positive for a marker of infection called \nhepatitis B surface antigen [HBsAg]). \n\nSource: United Nations Statistics Division\n","dato_global":"<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.3.4&seriesCode=SH_HAP_HBSAG&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=%3C5Y\">Prevalence of the Hepatitis B surface antigen (HBsAg) (%) SH_HAP_HBSAG</a> UNSTATS","comparabilidad":"The available indicator does not comply with United Nations metadata but provides similar information","indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-03-04.pdf\">Metadata 3-3-4.pdf</a>"},"target_number":"3.3","goal_number":"3","indicator_sort_order":"03-03-04"}